CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna’s COVID-19 Vaccine

eAwaz Medicine

Recommendation follows US FDA authorization for emergency use of a booster dose of the Moderna COVID-19 vaccine CAMBRIDGE – Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of a booster dose of the Moderna COVID-19 …

Bill & Melinda Gates Foundation to spend $120m on Merck’s antiviral covid pill

eAwaz Medicine

Los Angeles – Bill & Melinda Gates Foundation intend to spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral Covid pill for lower income countries, if approved by regulators. It hasn’t been determined how the foundation will allocate money, but they will use funds to support range of activities required to develop and manufacture generic versions …

Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses

eAwaz Medicine

CAMBRIDGE – Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Gavi, the Vaccine Alliance has exercised its option to purchase an additional 176.5 million doses of the Moderna COVID-19 vaccine for the COVAX Facility. Of these additional doses, 116.5 million doses are expected to be delivered in the first quarter of 2022 and 60 million …

Health Canada receives submission from Pfizer-BioNTech to authorize use of Comirnaty COVID-19 vaccine in kids 5 to 11 years of age

eAwaz Medicine

Ottawa – Health Canada received a submission from Pfizer-BioNTech seeking an authorization for the use of its Comirnaty COVID-19 vaccine in children 5 to 11 years of age. As with all COVID-19 vaccines, the Department will prioritize the review of this submission, while maintaining its high scientific standards for safety, efficacy and quality. This is the first submission Health Canada …

Chinia Vaccine Sinopharm and Sinovac

Are Chinese Covid jabs effective?

eAwaz Medicine

Beijing – Some studies have shown that the effectiveness of some of the Chinese CoronaVac and Sinopharm Covid vaccines may be waning in immunity levels. CoronaVac and Sinopharm account for almost 50 per cent of the 7.3 billion Covid-19 vaccine doses delivered globally. But Gagandeep Kang, a virologist at the Christian Medical College in India’s Vellore, who advises SAGE, has said: …

Moderna to Build State-of-the-Art Facility in Africa to Manufacture up to 500 Million Doses Per Year

eAwaz Medicine

CAMBRIDGE – Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50 µg dose level. The Company anticipates investing up to $500 million in this new facility which is expected to include drug …

Resurfacing treatment for post-menopause

eAwaz Medicine

TORONTO – A special type of laser resurfacing treatment popularly used for skin-related corrections is being marketed as an alternative treatment for a condition that affects women after menopause. Fractional carbon dioxide laser is a minimally-invasive procedure and improves look of skin damage. FDA has warned against it but Health Canada has approved several such devices for that specific use …

Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue

eAwaz Medicine

BELGIUM – The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced, in collaboration with the KU Leuven Rega Institute and the KU Leuven Centre for Drug Design and Discovery (CD3), the publication of new preclinical data in the journal Nature showing that an early-stage compound with a novel mechanism of action could potentially treat all serotypes of dengue fever …

Merck asks FDA to authorize anti-COVID-19 pill

eAwaz Medicine

WASHINGTON (AP) – Drugmaker Merck asked US regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic. If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to …